Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Mangalat, Nisha ^a   Liu, Yuying ^a   Fatheree, Nicole Y ^a   Ferris, Michael J ^b   van Arsdall, Melissa R ^a   Chen, Zhongxue ^c   Rahbar, Mohammad H ^c,d   Gleason, Wallace A ^a   Norori, Johana ^b   Tran, Dat Q ^a   Rhoads, J Marc ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DECREASED APPETITE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ENTERITIS; EPIPHORA; FECES ANALYSIS; FEMALE; FLATULENCE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; LACTOBACILLUS REUTERI; LOOSE FECES; MALE; NAUSEA; NORMAL HUMAN; NOSE CONGESTION; PARESTHESIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; RHINORRHEA; SIDE EFFECT; SORE THROAT; TONGUE NUMBNESS; VOMITING; WEIGHT REDUCTION;

ADULT; BIOLOGICAL MARKERS; CYTOKINES; DENATURING GRADIENT GEL ELECTROPHORESIS; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; LACTOBACILLUS REUTERI; LEUKOCYTE L1 ANTIGEN COMPLEX; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PROBIOTICS; TOLL-LIKE RECEPTORS; YOUNG ADULT;

LACTOBACILLUS REUTERI;

EID: 84866079730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043910     Document Type: Article

References (40)

1. Sanders ME, (2008) Probiotics: definition, sources, selection, and uses. Clin Infect Dis 46 Suppl 2: S58-61 discussion S144-151.
2. Savino F, Pelle E, Palumeri E, Oggero R, Miniero R, (2007) Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 119: e124-130.
3. Saavedra J, (2000) Probiotics and infectious diarrhea. Am J Gastroenterol 95: S16-18.
4. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K, (2004) Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70: 1176-1181.
5. Cannon JP, Lee TA, Bolanos JT, Danziger LH, (2005) Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24: 31-40.
6. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, et al. (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115: 178-181.
7. Kunz AN, Noel JM, Fairchok MP, (2004) Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 38: 457-458.
8. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM, (1999) Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 5: 290-292.
9. Luong ML, Sareyyupoglu B, Nguyen MH, Silveira FP, Shields RK, et al. (2010) Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection? Transpl Infect Dis 12: 561-564.
10. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, et al. (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371: 651-659.
11. Hempel S NS, Ruelaz A, Wang Z, Miles J, Suttorp M, et al. (2011) Safety of Probiotics to Reduce Risk and Prevent or Treat Disease. Rockville, MD. AHRQ Publication No. 11-E007. AHRQ Publication No. 11-E007.
12. Liu Y, Zhu L, Fatheree NY, Liu X, Pacheco SE, et al. (2009) Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297: G442-450.
13. Lin YP, Thibodeaux CH, Pena JA, Ferry GD, Versalovic J, (2008) Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis 14: 1068-1083.
14. Liu Y, Fatheree NY, Mangalat N, Rhoads JM, (2010) Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 299: G1087-1096.
15. Liu Y, Fatheree NY, Mangalat N, Rhoads JM, (2012) Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NFkappaB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 302: G608-G617.
16. Gomez-Llorente C, Munoz S, Gil A, (2010) Role of Toll-like receptors in the development of immunotolerance mediated by probiotics. Proc Nutr Soc 69: 381-389.
17. Vinderola G, Matar C, Perdigon G, (2005) Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin Diagn Lab Immunol 12: 1075-1084.
18. Lee JH, Lee B, Lee HS, Bae EA, Lee H, et al. (2009) Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int J Colorectal Dis 24: 231-237.
19. Hacini-Rachinel F, Nancey S, Boschetti G, Sardi F, Doucet-Ladeveze R, et al. (2009) CD4+ T cells and Lactobacillus casei control relapsing colitis mediated by CD8+ T cells. J Immunol 183: 5477-5486.
20. Judd TA, Day AS, Lemberg DA, Turner D, Leach ST, (2011) Update of fecal markers of inflammation in inflammatory bowel disease. J Gastroenterol Hepatol 26: 1493-1499.
21. Rosander A, Connolly E, Roos S, (2008) Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol 74: 6032-6040.
22. Cimperman L, Bayless G, Best K, Diligente A, Mordarski B, et al. (2011) A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 45: 785-789.
23. Mondel M, Schroeder BO, Zimmermann K, Huber H, Nuding S, et al. (2009) Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2: 166-172.
24. Kehl-Fie TE, Chitayat S, Hood MI, Damo S, Restrepo N, et al. (2011) Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell Host Microbe 10: 158-164.
25. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME, (2009) Probiotics and immunity. J Gastroenterol 44: 26-46.
26. Maeda S, Ohno K, Nakamura K, Uchida K, Nakashima K, et al. (2012) Increased expression of fractalkine and its receptor CX(3)CR1 in canine inflammatory bowel disease and their possible role in recruitment of intraepithelial lymphocytes. Vet Immunol Immunopathol 148 (3-4) (): 226-235.
27. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, et al. (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128: 541-551.
28. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, et al. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27: 3135-3142.
29. Janetzki S, Price L, Britten CM, van der Burg SH, Caterini J, et al. (2010) Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunol Immunother 59: 609-618.
30. Kofoed K, Schneider UV, Scheel T, Andersen O, Eugen-Olsen J, (2006) Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clin Chem 52: 1284-1293.
31. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP Jr, (2004) Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 61: 35-39.
32. Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, et al. (2005) Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem 51: 1102-1109.
33. Richens JL, Urbanowicz RA, Metcalf R, Corne J, O'Shea P, et al. (2010) Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen 15: 562-568.
34. Chowdhury F, Williams A, Johnson P, (2009) Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods 340: 55-64.
35. Mire-Sluis AR, Das RG, Padilla A, (1998) WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents. J Immunol Methods 216: 103-116.
36. Thorpe R, Wadhwa M, (2011) Intended use of reference products & WHO International Standards/Reference Reagents in the development of similar biological products (biosimilars). Biologicals 39: 262-265.
37. Nechansky A, Grunt S, Roitt IM, Kircheis R, (2008) Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking Differences. Biomark Insights 3: 227-235.
38. Breen EC, Reynolds SM, Cox C, Jacobson LP, Magpantay L, et al. (2011) Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol 18: 1229-1242.
39. Karimi K, Inman MD, Bienenstock J, Forsythe P, (2009) Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 179: 186-193.
40. O'Mahony C, Scully P, O'Mahony D, Murphy S, O'Brien F, et al. (2008) Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 4: e1000112.